Please Wait...

COL4 // Type IV Collagen

Biomarker Therapeutic Areas: 
Biomarker Matrices: 

Type Collagen IV is encoded by six genes: COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, and COL4A6 for the six collagen chain implicated in its composition: α1(IV) through α6(IV). The assembly of collagen IV network is highly regulated. Each of the six chains present the same features with three domains: short 7S N-Terminal, collagenous domain and non-collagenous domain (NC1) in C-terminal and can form three sets of helical molecules. Depending on the tissues the set of collagen type IV molecules is different. The α1.α1.α2(IV)-α1.α1.α2(IV) network is found in all basement membranes in the animal phyla, the α3.α4.α5(IV)-α3.α4.α5(IV) and the α1.α1.α2(IV)-α5.α5.α6(IV) are only found in mammalian basement membranes (Hudson et al., 2003). NC1 trimers also connect to form hexameric quaternary structure through head to head interaction and the collagen IV network is also formed through protomer-protomer interactions in the collagenous and covalent binding in the 7S domain (with four independent protomers)(Cummings and Hudson, 2014). Elevated serum and/or urinary content in Collagen IV can be found in patient with diabetic nephropathy and in some cancers (Banu et al., 1995; KINOSHITA et al., 2010; Nyström et al., 2015).

Bioclinica Lab employs a manual sandwich immunoassay for the measurement of Collagen IV in serum, plasma or urine.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Ck out best-of-breed trial #technologies & services: #RTSM, #esource, #EDC, site & patient #payments, global site… https://t.co/DJCNZ9C1uq
Bioclinica (Yesterday)
ICYMI: A discussion on recently released FDA draft guidance on assessment of blood pressure response in… https://t.co/7fmrkhhuQd
Bioclinica (Yesterday)
Our CIO & EVP Tech Gavin Nichols adds to #digitaltransformation discussion at #CMAsummit18 : W genomics & precision… https://t.co/oisqWvGJXC
Bioclinica (3 days ago)
Greetings from Tokyo where @bioclinica's Japan. China & US locations R@DrugInfoAssn DIA Japan. Discuss region-spec… https://t.co/HMzmFwA9pm
Bioclinica (5 days ago)
Reminder to join us in a live #Xtalks webinar tomorrow 11/6 on Electronic Data Capture (EDC). Everything clinical t… https://t.co/WS0L3QQnPv
Bioclinica (2 weeks ago)
Meet with representatives of Bioclinica's Japan, China & US locations at DIA Japan. Angel Y., Hidenori Seshimo & Er… https://t.co/j1alTH8oBm
Bioclinica (2 weeks ago)

Latest Blogs:

Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner